BCM
DXCM icon

BlueCrest Capital Management’s DexCom DXCM Stock Holding History

BlueCrest Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,000
Closed -$1.25M – 154
2024
Q1 		$1.25M Buy
+9,000
New +$1.13M 0.06% 148
2023
Q2 		– Sell
-4,200
Closed -$488K – 226
2023
Q1 		$488K Buy
+4,200
New +$470K 0.02% 189
2022
Q3 		– Sell
-5,550
Closed -$414K – 198
2022
Q2 		$414K Sell
5,550
-450
-8% -$41.1K 0.02% 155
2022
Q1 		$767K Sell
6,000
-536
-8% -$58.6K 0.03% 202
2021
Q4 		$877K Buy
6,536
+536
+9% +$77K 0.03% 231
2021
Q3 		$820K Hold
6,000
– – 0.02% 259
2021
Q2 		$641K Hold
6,000
– – 0.01% 409
2021
Q1 		$539K Hold
6,000
– – 0.01% 567
2020
Q4 		$555K Sell
6,000
-2,000
-25% -$179K 0.01% 321
2020
Q3 		$824K Buy
8,000
+4,000
+100% +$418K 0.03% 213
2020
Q2 		$405K Buy
+4,000
New +$358K 0.02% 198
2020
Q1 		– Sell
-17,920
Closed -$980K – 269
2019
Q4 		$980K Sell
17,920
-15,348
-46% -$728K 0.06% 157
2019
Q3 		$1.24M Buy
+33,268
New +$1.29M 0.09% 165
2018
Q4 		– Sell
-66,984
Closed -$2.4M – 1006
2018
Q3 		$2.4M Buy
+66,984
New +$2.08M 0.06% 220
2018
Q1 		– Sell
-116,964
Closed -$1.68M – 1513
2017
Q4 		$1.68M Buy
+116,964
New +$1.52M 0.05% 292
2017
Q2 		– Sell
-23,500
Closed -$498K – 954
2017
Q1 		$498K Buy
+23,500
New +$459K 0.02% 436
2016
Q4 		– Sell
-9,288
Closed -$204K – 714
2016
Q3 		$204K Buy
+9,288
New +$207K 0.01% 671
2015
Q4 		– Sell
-47,780
Closed -$1.03M – 1016
2015
Q3 		$1.03M Sell
47,780
-49,592
-51% -$1.11M 0.03% 443
2015
Q2 		$1.95M Buy
+97,372
New +$1.71M 0.06% 356

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlueCrest Capital Management's DXCM Position: Q2 2024 in Review

BlueCrest Capital Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 9,000 shares — an estimated $1.25M sold.

BlueCrest Capital Management first reported a position in DXCM in Q2 2015 and held it in 19 quarters. The position peaked at $2.4M in Q3 2018. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • BlueCrest Capital Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 9,000 DexCom shares in Q2 2024, an estimated $1.25M.
  • BlueCrest Capital Management first reported a position in DexCom in Q2 2015 and held it in 19 quarters.
  • BlueCrest Capital Management's DexCom position peaked at $2.4M in Q3 2018.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.